Cargando…

Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview

Colistin is used as a last-line antibiotic for the treatment of Gram-negative multiresistant bacteria. Due to its high nephrotoxicity, Therapeutic Drug Monitoring (TDM) is recommended for dose adjustment. We aimed to evaluate the available evidence of TDM in patients given colistin to treat Gram-neg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avila, Maria-Paula, Pacheco, Tatiana, Arias, Sara, Bustos, Rosa-Helena, Garcia, Julio-Cesar, Jaimes, Diego
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151705/ https://www.ncbi.nlm.nih.gov/pubmed/32155714 http://dx.doi.org/10.3390/ph13030042

Ejemplares similares

Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes
por: Sanabria, Jose, et al.
Publicado: (2021)

An Approach to Measuring Colistin Plasma Levels Regarding the Treatment of Multidrug-Resistant Bacterial Infection
por: Pacheco, Tatiana, et al.
Publicado: (2019)

Impact on Antibiotic Resistance, Therapeutic Success, and Control of Side Effects in Therapeutic Drug Monitoring (TDM) of Daptomycin: A Scoping Review
por: Osorio, Carolina, et al.
Publicado: (2021)

Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
por: Rodríguez, Sandra, et al.
Publicado: (2020)

Clinical Evidence of Magistral Preparations Based on Medicinal Cannabis
por: Arias, Sara, et al.
Publicado: (2021)

The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives
por: García, Julio-César, et al.
Publicado: (2018)

Optical Biosensors for Therapeutic Drug Monitoring
por: Garzón, Vivian, et al.
Publicado: (2019)

Synergistic Effects of Capric Acid and Colistin against Colistin-Susceptible and Colistin-Resistant Enterobacterales
por: Liu, Yi-Yun, et al.
Publicado: (2022)

Label-Free Quantification of Anti-TNF-α in Patients Treated with Adalimumab Using an Optical Biosensor
por: Bustos, Rosa Helena, et al.
Publicado: (2018)

Personalized Medicine for Antibiotics: The Role of Nanobiosensors in Therapeutic Drug Monitoring
por: Garzón, Vivian, et al.
Publicado: (2020)

Pseudomonas aeruginosa Coharboring Bla(KPC-2) and Bla(VIM-2) Carbapenemase Genes
por: Pacheco, Tatiana, et al.
Publicado: (2019)

Overview of Therapeutic Drug Monitoring
por: Kang, Ju-Seop, et al.
Publicado: (2009)

Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review
por: Rychlíčková, Jitka, et al.
Publicado: (2023)

Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks
por: Ehrentraut, Stefan Felix, et al.
Publicado: (2020)

Therapeutic Drug Monitoring in Arterial Hypertension
por: Seleznev, Sergey, et al.
Publicado: (2023)

Colistin resistance screening by 3 μg/ml colistin agar in Carbapenemase‐producing Enterobacterales
por: Soria‐Segarra, Claudia, et al.
Publicado: (2022)

An overview of colistin resistance, mobilized colistin resistance genes dissemination, global responses, and the alternatives to colistin: A review
por: Gharaibeh, Mohammad H., et al.
Publicado: (2019)

An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs
por: Jacob, Shery, et al.
Publicado: (2016)

Therapeutic drug monitoring for colistin therapy in severe multi-resistant Acinetobacter intracerebral abscess: A single case study with high-dose colistin and review of literature
por: Tafelski, Sascha, et al.
Publicado: (2017)

Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients
por: Gorham, Julie, et al.
Publicado: (2023)

Evaluation of two rapid phenotypical tests—Alifax rapid AST colistin test and Rapid Polymyxin NP test—for detection of colistin resistance in Enterobacterales
por: Germ, Julija, et al.
Publicado: (2021)

Selective digestive decontamination with oral colistin plus gentamicin for persistent bacteraemia caused by non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae in a neutropenic patient
por: Spencer-Sandino, Maria, et al.
Publicado: (2021)

Compensatory mutations modulate the competitiveness and dynamics of plasmid-mediated colistin resistance in Escherichia coli clones
por: Yang, Qiu E., et al.
Publicado: (2020)

XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin?
por: Del Giacomo, Paola, et al.
Publicado: (2022)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
por: Bradley, Nicole, et al.
Publicado: (2023)

Emergence of colistin resistance in the largest university hospital complex of São Paulo, Brazil, over five years()
por: Rossi, Flávia, et al.
Publicado: (2016)

Evaluation of a Screening Method for the Detection of Colistin-Resistant Enterobacteriaceae in Stool
por: Turbett, Sarah E, et al.
Publicado: (2019)

Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
por: Mena, Manuel, et al.
Publicado: (2023)

Colistin-resistant Escherichia coli belonging to different sequence types: genetic characterization of isolates responsible for colonization, community- and healthcare-acquired infections
por: Paiva, Yrving, et al.
Publicado: (2021)

1111. Therapeutic Drug Monitoring of Colistin in Cerebrospinal Fluid in the Treatment of Neurosurgical Meningitis caused by Pseudomonas aeruginosa and KPC-producing Enterobacterales
por: Yasmin, Mohamad, et al.
Publicado: (2021)

Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis
por: Lechtig-Wasserman, Sharon, et al.
Publicado: (2021)

Absence of mgrB Alleviates Negative Growth Effects of Colistin Resistance in Enterobacter cloacae
por: Wozniak, Jessie E., et al.
Publicado: (2020)

In vitro synergistic activity of colistin and teicoplanin combination against multidrug-resistant Acinetobacter spp
por: Rady, Osama Mohamed Samy Mohamed, et al.
Publicado: (2022)

Risk Factors for Colistin-Resistant Carbapenem-Resistant Klebsiella pneumoniae in the Postacute Care Setting
por: Zhang, Helen L, et al.
Publicado: (2022)

Administration and Therapeutic Drug Monitoring of β-lactams and Vancomycin in Critical Care Units in Colombia: The ANTIBIOCOL Study
por: Fuentes, Yuli V., et al.
Publicado: (2021)

Carbapenem-Resistant but Cephalosporin-Susceptible Pseudomonas aeruginosa in Urinary Tract Infections: Opportunity for Colistin Sparing
por: Gajdács, Márió
Publicado: (2020)

Implementation of screening criteria for inflammatory bowel disease in patients with spondyloarthritis and its association with disease and endoscopic activity
por: Gutiérrez-Sánchez, Jaiber, et al.
Publicado: (2022)

Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report
por: Garcia Casallas, Julio Cesar, et al.
Publicado: (2019)

Effectiveness of treatment with nebulized colistin in patients with COPD
por: Bruguera-Avila, Nuria, et al.
Publicado: (2017)

Successful use of intravitreal and systemic colistin in treating multidrug resistant Pseudomonas aeruginosa post-operative endophthalmitis
por: Samant, Preetam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n88cm3vp0or1rqp9vmfe76b663